Le Lézard
Classified in: Health, Covid-19 virus
Subject: NPT

RTI International's COVID-19 Experts Are Available to Comment on Past, Present and Future of Pandemic in Reflection of One-Year Anniversary


RESEARCH TRIANGLE PARK, N.C., March 4, 2021 /PRNewswire/ -- RTI International, a nonprofit research institute, has several COVID-19 experts available for media interviews. As the world reflects on the one-year anniversary of the COVID-19 pandemic ? proclaimed by the World Health Organization on March 11, 2020 ? RTI's scientists and researchers are available to provide insights on several topics, including virus variants, vaccines and distribution, global health systems, racial disparities and misinformation.

COVID researchers available to comment on variety of topics related to 3/11 anniversary from a science-based perspective

Throughout the past year, the researchers have used experiences from past pandemics, epidemics and public health crises, to help provide insight to public health officials and key stakeholders on the trajectory of the COVID-19 pandemic and evidence-based solutions for combatting the impacts.

Pia MacDonald, MPH, Ph.D., infectious disease epidemiologist at RTI

LaShawn Glasgow, DrPH, director of community and workplace health at RTI

Brian Southwell, Ph.D., senior director, Science in the Public Sphere, Center for Communication Science at RTI

Richard Reithinger, Ph.D. vice president of global health within RTI's International Development Group

Outside of the above experts and focus areas, RTI has additional experts available for media interviews which can be found by clicking here.

SOURCE RTI International


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: